Population-based pathogenic variant testing identified breast cancer susceptibility gene carriers who would often be missed ...
Genetic tests for cancer can run thousands of dollars, but Color Genomics plans to change that: it's offering testing for the cancer risk variants BRCA1 and BRCA2 — as well as 17 others — for $249, ...
Color, a population genomics and healthcare technology company that counts Apple, Verily and, most recently, Sioux Falls, S.D.-based Sanford Health among its partners, has closed a $75 million funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results